Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals

One approach to the development of an HIV vaccine is to design a protein template which can present gp120 epitopes inducing cross-neutralizing antibodies. To select a V3 sequence for immunogen design, we compared the neutralizing activities of 18 anti-V3 monoclonal antibodies (mAbs) derived from Cam...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Andrabi, Raiees, Williams, Constance, Wang, Xiao-Hong, Li, Liuzhe, Choudhary, Alok K., Wig, Naveet, Biswas, Ashutosh, Luthra, Kalpana, Nadas, Arthur, Seaman, Michael S., Nyambi, Phillipe, Zolla-Pazner, Susan, Gorny, Miroslaw K.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3756680/
https://ncbi.nlm.nih.gov/pubmed/23466102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2012.12.010
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares